Radcliffe Capital Management’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Radcliffe Capital Management’s Portfolio SHACW Stock Details SHACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-236,739	Closed	-$2.34M	–	1088
2022 Q3	$2.34M	Hold	236,739	–	–	0.06%	573
2022 Q2	$2.33M	Hold	236,739	–	–	0.05%	600
2022 Q1	$2.31M	Hold	236,739	–	–	0.05%	582
2021 Q4	$2.32M	Hold	236,739	–	–	0.06%	496
2021 Q3	$2.3M	Hold	236,739	–	–	0.07%	424
2021 Q2	$2.29M	Hold	236,739	–	–	0.07%	437
2021 Q1	$2.28M	Buy	+236,739	New	+$145K	0.09%	388

Radcliffe Capital Management's SHACW Position: Q4 2022 in Review

Radcliffe Capital Management sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 236,739 shares — an estimated $2.34M sold.

Radcliffe Capital Management first reported a position in SHACW in Q1 2021 and held it in 7 quarters. The position peaked at $2.34M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

Radcliffe Capital Management reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
Radcliffe Capital Management sold 236,739 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $2.34M.
Radcliffe Capital Management first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 7 quarters.
Radcliffe Capital Management's SCP & CO Healthcare Acquisition Company Warrant position peaked at $2.34M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Radcliffe Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.